ACTIVE LEARNING TEMPLATE: Medication
STUDENT NAME _____________________________________
Aspirin
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
Salicylates
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Produce analgesia and reduce inflammation Reduction of inflammation; reduction of
and fever by inhibiting the production of fever; decreased incidence of transient
prostaglandins. Decreases platelet ischemic attacks and MI.
aggregation.
Complications Medication Administration
GI bleeding, tinnitus, dypepsia, epigastric distress, PO: low dose - 81mgHighest:
anorexia, hepatotoxicity, anemia 975 mg chewable, enteric
coated, suppositories, delayed
release capsules.
Contraindications/Precautions
Hypersensitivity, bleeding disorder or thrombocytopenia,
may increase risk of Reye's syndrome
Nursing Interventions
Assess for rash, monitor hepatic
function, may casue ^ AST/ALT;
monitor serum salicylate levels,
prolong bleeding time for 4-7
days and large doses monitor
Interactions the hematocrit.
Warfarin, heparin, thrombolytic agents, clopidogrel,
tirofiban, hisotry of GI bleeding or ulcer disease, severe
hepatic disease.
Client Education
Take w/ full glass of water,
remain in upright position for
Evaluation of Medication Effectiveness 15-30 min after administration,
Reduces inflammation and platelet aggregation. report tinnitus or unusual
beeding, avoid concurrent use
of alcohol w/ this medication to
minimize possible gastric
irritation.
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
STUDENT NAME _____________________________________
Aspirin
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
Salicylates
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Produce analgesia and reduce inflammation Reduction of inflammation; reduction of
and fever by inhibiting the production of fever; decreased incidence of transient
prostaglandins. Decreases platelet ischemic attacks and MI.
aggregation.
Complications Medication Administration
GI bleeding, tinnitus, dypepsia, epigastric distress, PO: low dose - 81mgHighest:
anorexia, hepatotoxicity, anemia 975 mg chewable, enteric
coated, suppositories, delayed
release capsules.
Contraindications/Precautions
Hypersensitivity, bleeding disorder or thrombocytopenia,
may increase risk of Reye's syndrome
Nursing Interventions
Assess for rash, monitor hepatic
function, may casue ^ AST/ALT;
monitor serum salicylate levels,
prolong bleeding time for 4-7
days and large doses monitor
Interactions the hematocrit.
Warfarin, heparin, thrombolytic agents, clopidogrel,
tirofiban, hisotry of GI bleeding or ulcer disease, severe
hepatic disease.
Client Education
Take w/ full glass of water,
remain in upright position for
Evaluation of Medication Effectiveness 15-30 min after administration,
Reduces inflammation and platelet aggregation. report tinnitus or unusual
beeding, avoid concurrent use
of alcohol w/ this medication to
minimize possible gastric
irritation.
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
